International Stem Cell (ISCO) Return on Assets [ROA] (2011 - 2026)
International Stem Cell's Return on Assets [ROA] was -4.68% in Q2 2026, down 0.38 percentage points from -4.30% a year earlier.
Powered by 
Analysis
International Stem Cell (ISCO) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at International Stem Cell came in at -8.37%, down 4.33 percentage points from FY2024.
- Return on Assets [ROA] shows a five-year change of +40.86 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was -4.03% in FY2024 (+11.21 pp), -15.24% in FY2023 (-8.93 pp), -6.31% in FY2022 (+33.74 pp) and -40.05% in FY2021 (+9.18 pp).
- Quarterly Return on Assets [ROA] has moved between -46.38% (Q3 2021) and -1.07% (Q3 2025) over five years.
- Compared with a year earlier, Return on Assets [ROA] was higher in four of the last seven quarters, with an average year-over-year change of +4.59 percentage points.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q4 2022 (a gain of 35.22 percentage points); the worst was Q1 2024 (a drop of 11.71 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 10.60% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.14% |
| 10 | International Stem Cell | 1.36 Mn | -2.61 Mn | 1.46 Mn | -4.68% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.68% |
| Dec 31, 2025 | -8.28% |
| Sep 30, 2025 | -1.07% |
| Jun 30, 2025 | -4.30% |
| Mar 31, 2025 | -4.72% |
| Dec 31, 2024 | -4.11% |
| Sep 30, 2024 | -12.68% |
| Jun 30, 2024 | -12.57% |
| Mar 31, 2024 | -18.25% |
| Dec 31, 2023 | -14.54% |
| Sep 30, 2023 | -5.53% |
| Jun 30, 2023 | -9.35% |
| Mar 31, 2023 | -6.55% |
| Dec 31, 2022 | -6.25% |
| Sep 30, 2022 | -13.58% |
| Jun 30, 2022 | -18.61% |
| Mar 31, 2022 | -27.93% |
| Dec 31, 2021 | -41.47% |
| Sep 30, 2021 | -46.38% |
| Jun 30, 2021 | -45.25% |
API Access
International Stem Cell Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();